A critical discovery in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in several kinds of malignancies, leading https://bookmarksusa.com/story22027337/nanobodies-reactivate-p53-new-promising-hope-for-tumor-treatment